After Vertex President and CEO Reshma Kewalramani presented at the firm’s healthcare conference, JPMorgan analyst Jessica Fye notes that the ...

J.P. Morgan analyst Jessica Fye has maintained their bullish stance on VRTX stock, giving a Buy rating today.Stay Ahead of the Market:Discover ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) 43rd Annual J.P. Morgan Healthcare Conference January 13, 2025 10:30 AM ETCompany ParticipantsDr.

Our analyst team just revealed what they believe are the 10 best stocks to buy right now. See the 10 stocks » 1. Amazon Few companies enjoy as strong of a competitive moat as Amazon (NASDAQ: AMZN).

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved ALYFTREK (vanzacaftor/tezacaftor ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced multiple program updates ahead of upcoming investor ...

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.

A new treatment for cystic fibrosis has been approved by the U.S. Food and Drug Administration (FDA).

Jan. 1, 2025 — Researchers have traced a cellular route Ebola virus (EBOV) uses to traverse the inner and outer layers of skin and emerge onto the skin's surface. The study identifies new cell ...

Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions.

The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...

John George, 37, was last in touch with his family on 14 December when he drove from Alicante to Benidorm. The baby born was born less than an hour before Spanish rescuers reached the crowded raft ...